Aspen Pharmacare Holdings Limited Stock price

Equities

APN

ZAE000066692

Pharmaceuticals

End-of-day quote Johannesburg S.E. 06:00:00 2024-02-22 pm EST 5-day change 1st Jan Change
195 ZAR -0.65% Intraday chart for Aspen Pharmacare Holdings Limited -0.17% -4.17%
Sales 2024 * 44.84B 2.33B Sales 2025 * 50.19B 2.61B Capitalization 87.34B 4.53B
Net income 2024 * 6.77B 351M Net income 2025 * 8.05B 418M EV / Sales 2024 * 2.39 x
Net Debt 2024 * 19.98B 1.04B Net Debt 2025 * 16.52B 858M EV / Sales 2025 * 2.07 x
P/E ratio 2024 *
13.3 x
P/E ratio 2025 *
10.6 x
Employees 8,887
Yield 2024 *
1.84%
Yield 2025 *
2.14%
Free-Float 80.22%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Aspen Pharmacare Holdings Limited

1 day+1.16%
1 week+0.48%
Current month+1.14%
1 month-2.78%
3 months+11.81%
6 months+4.62%
Current year-3.54%
More quotes
1 week
192.05
Extreme 192.05
199.51
1 month
185.41
Extreme 185.41
202.85
Current year
185.41
Extreme 185.41
206.39
1 year
137.75
Extreme 137.75
206.39
3 years
128.89
Extreme 128.89
281.67
5 years
64.07
Extreme 64.07
281.67
10 years
64.07
Extreme 64.07
448.68
More quotes
Managers TitleAgeSince
Founder 60 -
Director of Finance/CFO 57 98-12-31
Chief Operating Officer 60 98-12-31
Members of the board TitleAgeSince
Director/Board Member 63 98-12-31
Founder 60 -
Chairman 53 12-03-31
More insiders
Date Price Change Volume
24-02-22 195 -0.65% 2 179 155
24-02-22 196.3 +1.16% 769,198
24-02-21 194 -1.63% 845,849
24-02-20 197.2 -0.85% 905,831
24-02-19 199 -0.12% 478,501

End-of-day quote Johannesburg S.E., February 21, 2024

More quotes
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows: - pharmaceuticals (71.6%): anaesthetics products, thrombosis products, cytotoxic products, etc.; - other (28.4%): infant nutrition products and consumer products. At the end of June 2022, the group had 16 production sites worldwide.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
196.3 ZAR
Average target price
214.7 ZAR
Spread / Average Target
+9.37%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Aspen Pharmacare Holdings Limited - Johannesburg S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer